144 related articles for article (PubMed ID: 35419462)
1. Concurrent Chemoradiotherapy Increases the Levels of Soluble Immune Checkpoint Proteins in Patients with Locally Advanced Cervical Cancer.
Liu C; Li X; Li A; Zou W; Huang R; Hu X; Yu J; Zhang X; Yue J
J Immunol Res; 2022; 2022():9621466. PubMed ID: 35419462
[TBL] [Abstract][Full Text] [Related]
2. Immune Checkpoint Axes Are Dysregulated in Patients With Alcoholic Hepatitis.
Li W; Xia Y; Yang J; Guo H; Sun G; Sanyal AJ; Shah VH; Lou Y; Zheng X; Chalasani N; Yu Q
Hepatol Commun; 2020 Apr; 4(4):588-605. PubMed ID: 32258953
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant Chemoradiotherapy Changes the Landscape of Soluble Immune Checkpoint Molecules in Patients With Locally Advanced Rectal Cancer.
Liu C; Wang P; Sun Y; Dou X; Hu X; Zou W; Sun Y; Hu Q; Yue J
Front Oncol; 2022; 12():756811. PubMed ID: 35530332
[TBL] [Abstract][Full Text] [Related]
4. Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial Chemoembolization.
Odagiri N; Hai H; Thuy LTT; Dong MP; Suoh M; Kotani K; Hagihara A; Uchida-Kobayashi S; Tamori A; Enomoto M; Kawada N
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32722224
[TBL] [Abstract][Full Text] [Related]
5. The Dynamic Alternation of Local and Systemic Tumor Immune Microenvironment During Concurrent Chemoradiotherapy of Cervical Cancer: A Prospective Clinical Trial.
Li R; Liu Y; Yin R; Yin L; Li K; Sun C; Zhou Z; Li P; Tong R; Xue J; Lu Y
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1432-1441. PubMed ID: 33713744
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of circulating soluble immune checkpoint proteins in sorafenib-treated patients with advanced hepatocellular carcinoma.
Dong MP; Enomoto M; Thuy LTT; Hai H; Hieu VN; Hoang DV; Iida-Ueno A; Odagiri N; Amano-Teranishi Y; Hagihara A; Fujii H; Uchida-Kobayashi S; Tamori A; Kawada N
Sci Rep; 2020 Feb; 10(1):3392. PubMed ID: 32099055
[TBL] [Abstract][Full Text] [Related]
7. Correlations between alterations of T-helper 17 cells and treatment efficacy after concurrent radiochemotherapy in locally advanced cervical cancer (stage IIB-IIIB): a 3-year prospective study.
Liu Y; Guo QF; Chen JL; Li XR; Hou F; Liu XY; Zhang WJ; Zhang Y; Gao FF; Zhang YZ; Cui BX; Liu NF
Chin Med J (Engl); 2021 Apr; 134(8):954-962. PubMed ID: 33840740
[TBL] [Abstract][Full Text] [Related]
8. Operation for locally advanced cervical cancer after concurrent chemoradiotherapy.
Ge J; Sun J; Li J; Zhang Q; Lv X; Chen B
Int J Clin Oncol; 2020 May; 25(5):948-954. PubMed ID: 32236755
[TBL] [Abstract][Full Text] [Related]
9. Modulated electrohyperthermia in locally advanced cervical cancer: Results of an observational study of 95 patients.
Lee SY; Lee DH; Cho DH
Medicine (Baltimore); 2023 Jan; 102(3):e32727. PubMed ID: 36701697
[TBL] [Abstract][Full Text] [Related]
10. Chemoradiotherapy with hyperthermia versus chemoradiotherapy alone in locally advanced cervical cancer: a systematic review and meta-analysis.
Yea JW; Park JW; Oh SA; Park J
Int J Hyperthermia; 2021; 38(1):1333-1340. PubMed ID: 34477028
[TBL] [Abstract][Full Text] [Related]
11. Chemoradiotherapy treatment with gemcitabine improves renal function in locally advanced cervical cancer patients with renal dysfunction.
Alarcón-Barrios S; Luvián-Morales J; Castro-Eguiluz D; Delgadillo-González M; Lezcano-Velázquez BO; Arango-Bravo EA; Flores-Cisneros L; Aguiar Rosas S; Cetina-Pérez L
Curr Probl Cancer; 2024 Feb; 48():101041. PubMed ID: 37988902
[TBL] [Abstract][Full Text] [Related]
12. Strain elastography imaging for early detection and prediction of tumor response to concurrent chemo-radiotherapy in locally advanced cervical cancer: feasibility study.
Xu Y; Zhu L; Liu B; Ru T; Wang H; He J; Liu S; Yang X; Zhou Z; Liu T
BMC Cancer; 2017 Jun; 17(1):427. PubMed ID: 28629386
[TBL] [Abstract][Full Text] [Related]
13. Soluble type immune checkpoint regulators using multiplex luminex immunoassay in chronic hepatitis B patients.
Fadriquela A; Kim CS; Lee KJ; Kang SH; Kim MY; Lee JH
J Clin Pathol; 2021 Dec; 74(12):780-786. PubMed ID: 34016716
[TBL] [Abstract][Full Text] [Related]
14. Association between MRI histogram features and treatment response in locally advanced cervical cancer treated by chemoradiotherapy.
Perucho JAU; Wang M; Tse KY; Ip PPC; Siu SWK; Ngan HYS; Khong PL; Lee EYP
Eur Radiol; 2021 Mar; 31(3):1727-1735. PubMed ID: 32885298
[TBL] [Abstract][Full Text] [Related]
15. Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Pyo JY; Yoon T; Ahn SS; Song JJ; Park YB; Lee SW
Sci Rep; 2022 Dec; 12(1):21319. PubMed ID: 36494415
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of nimotuzumab combined with chemoradiotherapy in the treatment of locally advanced cervical cancer.
Zhang L; Jiang Y; Jiang P; Chen Z; Cui H; Zhang Y
Ann Transl Med; 2022 Dec; 10(24):1322. PubMed ID: 36660627
[TBL] [Abstract][Full Text] [Related]
17. Cost-utility analysis of adjuvant chemotherapy after concurrent chemoradiation in patients with locally advanced cervical cancer.
Rongsriyam K; Tangjitgamol S; Leelahavarong P; Teerawattananon Y; Tharavichitkul E; Tovanabutra C; Asakij T; Paengchit K; Sukhaboon J; Penpattanagul S; Kridakara LCA; Hanprasertpong J; Khunnarong J; Chottetanaprasith T; Lorvidhaya V
J Med Imaging Radiat Oncol; 2020 Dec; 64(6):873-881. PubMed ID: 32978901
[TBL] [Abstract][Full Text] [Related]
18. Individualized pelvic lymphadenectomy should follow neoadjuvant concurrent chemoradiotherapy for locally advanced cervical cancer.
Wei LC; Li X; Zhang Y; Dang YZ; Li WW; Li JP; Zhao LN; Liu SJ; Li X; Shi M
Medicine (Baltimore); 2018 Apr; 97(14):e0331. PubMed ID: 29620659
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Hematological Parameters in Locally Advanced Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy.
Lee HJ; Kim JM; Chin YJ; Chong GO; Park SH; Lee YH; Hong DG; Lee YS
Anticancer Res; 2020 Jan; 40(1):451-458. PubMed ID: 31892600
[TBL] [Abstract][Full Text] [Related]
20. Characterization of multiple soluble immune checkpoints in individuals with different Mycobacterium tuberculosis infection status and dynamic changes during anti-tuberculosis treatment.
Chen H; Zhou J; Zhao X; Liu Q; Shao L; Zhu Y; Ou Q
BMC Infect Dis; 2022 Jun; 22(1):543. PubMed ID: 35701741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
